Clik here to view.
Approval for Listing of Shares of Solasia on the Tokyo Stock Exchange Mothers
TOKYO Solasia Pharma K.K. (Headquarters: Tokyo, Japan, President and CEO: Yoshihiro Arai, hereinafter “Solasia”) an oncology specialized pharmaceutical company developing oncology products for Asian...
View ArticleClik here to view.
EP Vantage Releases its Annual Pharma and Medtech Sector Review Reports for 2016
LONDON, BOSTON, SAN FRANCISCO & TOKYO For the world’s drug makers 2016 was a year of two halves. Dealmaking and venture funding held up over the first two quarters, buoyed by the retreating bull...
View ArticleClik here to view.
Initial Results Positive for CelGro® in Human Nerve Regeneration
PERTH, Australia Regenerative medicine company Orthocell is pleased to announce positive initial safety and tolerability results for its CelGro® collagen-based medical device, in a clinical study...
View ArticleClik here to view.
レマン・マイクロ・デバイセズのスマートフォン組み込み型ヘルスモニタリングシステムは世界で初めて医学的に正確な測定が可能となり、FDA承認の取得に向け準備完了
スイス・ローザンヌ （ビジネスワイヤ） — 認可済みコンシューマーヘルスケア製品の開発企業としてモバイルデバイス業界の大企業から支持されているレマン・マイクロ・デバイセズ（LMD）は、当社のHealth Sensor & AppがFDA、その他の世界各国の規制当局に申請する準備が完了したと発表しました。Health Sensor &...
View ArticleClik here to view.
Truxima™, the first biosimilar mAb in oncology, granted EU marketing...
INCHEON, South Korea Celltrion Healthcare today announced that the European Commission has approved Truxima™ (biosimilar rituximab) for all indications of reference rituximab in the European Union...
View ArticleClik here to view.
Herbalife Ltd. Reaches Agreement in Principle to Form Joint Venture with...
LOS ANGELES Herbalife Ltd. (NYSE: HLF), a global nutrition company, today announced it has reached an agreement in principle to form a joint venture with Tasly Holding Group, a leading Traditional...
View ArticleClik here to view.
サンバイオの脳梗塞に対する幹細胞治療が米国心臓協会からイノベーション・アワードを受賞
米カリフォルニア州マウンテンビュー （ビジネスワイヤ） — 神経系疾患を対象に再生細胞薬の開発・製造を手掛ける当社グループ（サンバイオ株式会社及びその子会社であるSanBio, Inc.） は、米国心臓協会（American Heart Association）の発行する医療専門誌Strokeで論文発表された骨髄由来間葉系幹細胞を使った脳梗塞治験フェーズ1/2a（本試験）について、2016...
View ArticleClik here to view.
Study of SanBio’s Stem Cell Treatment for Stroke Receives Innovation Award...
MOUNTAIN VIEW, Calif. SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, today announced that a recent publication of its novel stem cell treatment, SB623, for...
View ArticleClik here to view.
Waters Honors Singapore’s Bioprocessing Technology Institute (BTI) for...
MILFORD, Mass. At a ceremony and symposium today, Waters Corporation (NYSE:WAT) welcomed into its Centers of Innovation Program the Bioprocessing Technology Institute (BTI), a research institute...
View ArticleClik here to view.
joimax® Obtains Full Product Registration in Thailand, and is Now Active in...
IRVINE, Calif. joimax® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding...
View ArticleClik here to view.
Evaluate: Median Cost Per Patient for Orphan Drugs is 5.5 Times Higher Than...
LONDON, BOSTON & TOKYO The steady and inexorable growth of the orphan drug market remains one of the prominent themes in the fourth edition of the EvaluatePharma Orphan Drug Report 2017. What...
View ArticleClik here to view.
Baxter and ScinoPharm Announce Exclusive Strategic Partnership for Generic...
DEERFIELD, Ill. & TAINAN, Taiwan Baxter International Inc. (NYSE: BAX) and ScinoPharm Taiwan, Ltd. (TWSE: 1789) today announced a strategic partnership to develop, manufacture and commercialize...
View ArticleClik here to view.
Pharmaron Acquires Majority Stake in SNBL CPC
BEIJING Pharmaron, a fully integrated contract research organization offering R&D services to the life sciences industry, today announced that it has signed a definitive agreement under which...
View ArticleClik here to view.
新研究评估Masimo PVi®监测在结直肠手术中的功用
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布近期一项在低危结直肠手术患者中开展的研究的结果，研究人员在该研究中评估Masimo PVi®（脉搏灌注变异指数）无创连续监测在指导补液管控中的功用，并与创伤性的监测方法食管多普勒相比较。研究人员未发现这两种技术的平均总补液量有显著差异，因此断言，“PVi可为该组患者目的为导向治疗提供完全无创替代方法。1”...
View ArticleClik here to view.
Invenra and QIMR Berghofer Medical Research Institute Enter Collaboration to...
MADISON, Wis. & HERSTON, Australia Invenra, Inc., a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies, bispecifics and antibody derivatives,...
View ArticleClik here to view.
Avita Medical Named to 2017 OTCQX Best 50
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England Avita Medical Limited (ASX:AVH) (OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects,...
View ArticleClik here to view.
US Medical Device Company Visioneering Technologies, Inc. to List On ASX –...
ALPHARETTA, Georgia Visioneering Technologies, Inc. (VTI), a US based medical device company, is pleased to announce the opening of its fully underwritten Initial Public Offering (IPO) to raise...
View ArticleClik here to view.
Octapharma Group公布2016年业绩，录得营收16亿欧元，运营收入3.83亿欧元
瑞士拉亨 (美国商业资讯)–Octapharma Group公布了创纪录的业绩，其销售额达到了16亿欧元，较2015年增长5.8%，或增长8,700万欧元。 Octapharma的北美销售额增长了18.8%，东欧增长了14%，西欧成熟市场增长了6%。业绩增长主要归功于Octapharma的免疫球蛋白产品octagam® 和gammanorm®...
View ArticleClik here to view.
Mauna Kea Technologies: Superiority of Endomicroscopy for the Diagnosis of...
PARIS Regulatory News: Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced...
View ArticleClik here to view.
大塚製薬による米国バイオベンチャー「ニューロバンス社」の買収について
東京 （ビジネスワイヤ） – 大塚製薬株式会社（本社：東京都、代表取締役社長：樋口達夫、以下「大塚製薬」）はNeurovance, Inc.（本社：米国マサチューセッツ州ケンブリッジ、 Executive Chairman & CEO：ジェフ・ベイリー、以下「ニューロバンス社」）と、3月2日（米国東部時間）、大塚アメリカインク（大塚製薬の100%子会社：Otsuka America...
View Article